LINCOLN PHARMACEUTICALS
Back to All Ratios
|
LINCOLN PHARMACEUTICALS Last 5 Year Return on Capital Employed (ROCE) History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
ROCE(%) | 22.53 | 21.82 | 24.29 | 24.90 | 22.30 |
What is the latest Return on Capital Employed (ROCE) ratio of LINCOLN PHARMACEUTICALS ?
Year | Return on Capital Employed (ROCE) |
---|---|
Mar2024 | 22.53 |
Mar2023 | 21.82 |
Mar2022 | 24.29 |
Mar2021 | 24.90 |
Mar2020 | 22.30 |
How is Return on Capital Employed (ROCE) of LINCOLN PHARMACEUTICALS Trending?
Years | Return on Capital Employed (ROCE) | % Change | |
---|---|---|---|
Mar2024 | 22.53 | 3.25 | |
Mar2023 | 21.82 | -10.17 | |
Mar2022 | 24.29 | -2.45 | |
Mar2021 | 24.9 | 11.66 | |
Mar2020 | 22.3 | - |
Other Financial Ratios of LINCOLN PHARMACEUTICALS
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Return on Capital Employed (ROCE) ratio of peers of LINCOLN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LINCOLN PHARMACEUTICALS | ₹1,093.4 Cr | -0.2% | -4.5% | -6.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,865.0 Cr | -0.5% | -8.4% | 14.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,574.0 Cr | -2.4% | 7.2% | 50.6% | Stock Analytics | |
CIPLA | ₹118,710.0 Cr | -0.7% | -3.7% | -1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹105,964.0 Cr | -1.4% | -3.9% | 19% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,232.0 Cr | 0.5% | 5.6% | 5.1% | Stock Analytics |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LINCOLN PHARMACEUTICALS | -0.2% |
-4.5% |
-6.6% |
SENSEX | -1% |
1.4% |
7.9% |
You may also like the below Video Courses